Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine
Saved in:
| Published in | Journal of the neurological sciences Vol. 455; p. 121116 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
01.12.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| ArticleNumber | 121116 |
|---|---|
| Author | Richardson, Diane R. Vargas, Bert B. Myers Oakes, Tina M. Pandey, Hitendra N. Goadsby, Peter J. Schwedt, Todd J. Meyer, Michael Cobas Martinez, James M. Varnado, Oralee J. Pearlman, Eric M. |
| Author_xml | – sequence: 1 givenname: Todd J. surname: Schwedt fullname: Schwedt, Todd J. organization: Mayo Clinic, Department of Neurology, Phoenix, United States of America – sequence: 2 givenname: Tina M. surname: Myers Oakes fullname: Myers Oakes, Tina M. organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 3 givenname: James M. surname: Martinez fullname: Martinez, James M. organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 4 givenname: Bert B. surname: Vargas fullname: Vargas, Bert B. organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 5 givenname: Hitendra N. surname: Pandey fullname: Pandey, Hitendra N. organization: Eli Lilly and Company, Statistics, Bangalore, India – sequence: 6 givenname: Eric M. surname: Pearlman fullname: Pearlman, Eric M. organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 7 givenname: Diane R. surname: Richardson fullname: Richardson, Diane R. organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 8 givenname: Oralee J. surname: Varnado fullname: Varnado, Oralee J. organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 9 givenname: Michael Cobas surname: Meyer fullname: Meyer, Michael Cobas organization: Eli Lilly and Company, Neuroscience, Indianapolis, United States of America – sequence: 10 givenname: Peter J. surname: Goadsby fullname: Goadsby, Peter J. organization: King's College London, Nihr-king’s Clinical Research Facility, London, United Kingdom |
| BookMark | eNp9kcuO1DAQRbMYpHkwH8DOHzBpbCfOgwUSagEz0kgsAImdVbHLaYfEjuykpcxH8Y04aiRWsCrV4p66OnWbXTnvMMveMHpglFVvh8Pg4oFTXhwYZ4xVV9kNpZzngtEf19ltjAOltGqa9ib7dTzBOKLrMZ9s_44AmU8QkZQPJIDTfrIvqB-I9ms3Yt6N1v3d9DpNG4nLqjei_DRDsK4nywkJGmMVqI0kBIlgcNmIN6SHUYHDl3WCjpwxxDWSYCfscQa3EOMDmQOe0S3Wuz2As41eW0VStwDW4evslYEx4v2feZd9__Tx2_Exf_7y-en44TlXrKzL3OjaiKIsK8NU21CkSohS6IKjZqalHRQCNHQtQMNrCrXomppjTYWoWN1RLO4yduGq4GMMaOScikLYJKNylywHmSTLXbK8SE6Z95cMpmJni0GqpCt5GH_ihnHwa3Cps2Qycknl1_0l-0d4Qamo6zIB2n8DpPb2P8d_AwR3oHA |
| ContentType | Journal Article |
| Copyright | 2023 |
| Copyright_xml | – notice: 2023 |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.jns.2023.121116 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EndPage | 121116 |
| ExternalDocumentID | 10_1016_j_jns_2023_121116 1_s2_0_S0022510X23005774 S0022510X23005774 |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABFRF ABGSF ABIVO ABJNI ABLJU ABMAC ABMZM ABTEW ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HMQ HVGLF HZ~ IHE J1W KOM L7B LX8 M29 M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SSH SSN SSU SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAYXX AGRNS CITATION |
| ID | FETCH-LOGICAL-c1474-fd7f53446f1c980e0c5545d32ed1f90ba35adab9aa8270a75b872e7055617b0e3 |
| ISSN | 0022-510X |
| IngestDate | Tue Jul 01 00:51:22 EDT 2025 Sun Feb 23 10:19:15 EST 2025 Tue Aug 26 16:33:48 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1474-fd7f53446f1c980e0c5545d32ed1f90ba35adab9aa8270a75b872e7055617b0e3 |
| PageCount | 1 |
| ParticipantIDs | crossref_primary_10_1016_j_jns_2023_121116 elsevier_clinicalkeyesjournals_1_s2_0_S0022510X23005774 elsevier_clinicalkey_doi_10_1016_j_jns_2023_121116 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2023 |
| PublicationDateYYYYMMDD | 2023-12-01 |
| PublicationDate_xml | – month: 12 year: 2023 text: December 2023 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of the neurological sciences |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| SSID | ssj0006889 |
| Score | 2.410873 |
| SourceID | crossref elsevier |
| SourceType | Index Database Publisher |
| StartPage | 121116 |
| SubjectTerms | Neurology |
| Title | Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0022510X23005774 https://www.clinicalkey.es/playcontent/1-s2.0-S0022510X23005774 |
| Volume | 455 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiKdYXvKBE9lEeTgvbuwKtFqpcKCLeovs2GbbpU3VhxA98JP4PfwcZpw4SZeCWC5Rk9SulfnqGTvffEPIy0wmnOtIu4FS3GVCRviSMHcz7qdKZyxTGhOch--T03N2No7Hg8HPHmtpsxZeud2bV_I_VoVrYFfMkr2GZdtO4QJ8BvvCESwMx3-y8YmthOLOJk3a8uIC3JLD8MmBF5LVbLKttzNltRFflCsgrOyfSxjut1pktuGj2_wpheISWAzebK1zrWruBngUsIbabmZcOMjp2KwcLBHwGfwa6jxVS9QdsCxKaKAWk1UlJ6UDY8R6FLvcoy4ext806pp2Nm6ccxv0fywvvippnMaoktI581q04LrB-cAv6zlvNJlzZ9jdNUoJ9U65IQX37n3COr-m0bFarp1jr78LEkY9RkmXlQDzy7g_s7M47s3NKGZX53X-5jbqHYypN52jgnsYed13dyW6r7jOltBouXLTAroosIui7uIGuRnCAgZra3jfO_JRkmW51bHHUdv37YZ5eGUU-yOmXhQ0ukvuNOaib2os3iMDNb9Pbg0bgsYD8mMHkq8ppwaQlB3RDo5HtA_G9sxAkRoo0haKFGBBLRQpdEFrKNJK0z4UaQ1F2kGRAhRpB0VsYKFILRQfkvN3b0cnp25TEsQtA5YyV8tUxxFjiQ7KPPOVX0I4HMsoVDLQuS94FHPJRc55FqY-T2ORpaEyilFBKnwVPSIH82quHhMaMB5D9KalTgRTeShSKXOuRZkwjKKzQ_LKPvZiUSu_FH808yEJrWEKm9IMTrgAgP2tUbqvkVo1U8yqCIpVWPgFMipChEmIxSVgwfbkOmN7Sm53_5hn5GC93KjnEEmvxQsDyl_dMM7N |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Challenge-mig%3A+a+phase+4%2C+randomized%2C+double-blind%2C+double-dummy+study+comparing+the+efficacy+and+safety+of+galcanezumab+versus+rimegepant+for+prevention+of+episodic+migraine&rft.jtitle=Journal+of+the+neurological+sciences&rft.au=Schwedt%2C+Todd+J.&rft.au=Myers+Oakes%2C+Tina+M.&rft.au=Martinez%2C+James+M.&rft.au=Vargas%2C+Bert+B.&rft.date=2023-12-01&rft.issn=0022-510X&rft.volume=455&rft.spage=121116&rft_id=info:doi/10.1016%2Fj.jns.2023.121116&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jns_2023_121116 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0022510X%2FS0022510X23X00136%2Fcov150h.gif |